Investor Relations
Sign up for email alerts
Sign Up Today
Stock Information
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.
Company Overview
Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Volition's research and development activities are centered in Belgium, with a small laboratory in California and additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.
Management Team
Cameron Reynolds MBA
President & Chief Executive Officer
Cameron is an experienced entrepreneurial executive, with expertise in biotechnology companies. He has extensive experience in the management, structuring, and strategic planning of start-up companies and has held positions including Chief View Full Bio
Terig Hughes
Chief Financial Officer
Mr. Hughes is a seasoned finance professional with over twenty-five years of accounting, finance and business management experience gained through an international career spanning the United States, Europe and Asia and joins Volition from View Full Bio
Dr. Gaetan Michel
Chief Operating Officer
Dr. Gaetan Michel has been with Volition almost seven years, previously serving as Chief Operating Officer of Belgian Volition and currently as Chief Executive Officer of Belgian Volition. With over 15 years of project management, View Full Bio
Jake Micallef PhD MBA
Chief Scientific Officer
Jake is an experienced scientist with expertise in research and development and in the management of early stage biotechnical companies, including the manufacturing of biotechnology products and the establishment of manufacturing View Full Bio
Louise Batchelor
Chief Marketing and Communications Officer
Louise brings more than 20 years of marketing, sales and leadership experience to her role at Volition. Since 2011, she has served as Director and Owner of Aculd Ltd, a strategic marketing consultancy specializing in healthcare. Formerly View Full Bio
Gael Forterre
Chief Commercial Officer
Mr. Gael Forterre has over 15 years of experience investing in and scaling fast growing companies. Mr. Forterre started his career as a hedge fund analyst in Paris and worked in a number of investment banking and trading roles over ten View Full Bio
Jason Terrell MD
Chief Medical Officer & Chief Executive Officer of Volition America, Inc.
Jason has expertise in clinical medicine and in laboratory diagnostics. He was educated at Hardin-Simmon University (Biochemistry) where he graduated Summa Cum Laude, also receiving the Holland Medal of Honor. He received his Doctor of View Full Bio
Jasmine Kway PhD
Chief Executive Officer, Singapore Volition
Jasmine has a proven track record in achieving positive business results by developing strategic business alliances, identifying new markets, and developing business processes. As a thought leade in technology management and View Full Bio
Dr. Tom Butera DVM
Chief Executive Officer of Volition Veterinary Diagnostic Development LLC
Tom Butera is a Doctor of Veterinary Medicine with more than 40 years of experience in equine and small animal health in private practice as well as extensive work in both business development and management of veterinary companies. Since View Full Bio
Dr. Mark Eccleston
Chief Technology Officer
Dr. Mark Eccleston, one of Volition's founding scientists will now serve as our new Chief Technology Officer. Dr. Eccleston has over 20 years' experience in the biotechnology sector and holds a PhD in Polymer Chemistry for biomedical View Full Bio
Rod Rootsaert LLB
Corporate Secretary
Rod is an experienced legal and corporate secretary with over ten years’ experience in providing corporate, legal and administrative services to start-up companies. He previously served as corporate secretary for several junior View Full Bio
Scott Powell PhD
Executive Vice President, Investor Relations & Chief Financial Officer of Volition America, Inc.
Scott has nearly 20 years of experience in the U.S. capital markets and investor relations. Scott has served as Head of Investor Relations for four public companies, including Volition, and worked for several years as an View Full Bio
Dr. Martin C Faulkes
Chairman
Dr. Martin Faulkes has over 30 years of entrepreneurial and managerial experience as the founder and CEO of several software companies within the United Kingdom and the United States.
From 1979 to 1984, Dr. Faulkes was the Founder, View Full Bio
Cameron Reynolds MBA
President & Chief Executive Officer
Cameron is an experienced entrepreneurial executive, with expertise in biotechnology companies. He has extensive experience in the management, structuring, and strategic planning of start-up companies and has held positions including Chief View Full Bio
Dr. Phillip Barnes
Non-Executive Director
Dr. Barnes is a British physician with extensive experience both as a clinician and clinical manager within the UK National Health Service ("NHS") and related academic institutions. Dr. Barnes was also involved in a number of national and View Full Bio
Dr. Alan Colman
Non-Executive Director
Alan Colman obtained a BA degree in Biochemistry in Oxford (1971) and a PhD under John Gurdon, a pioneer of the field of nuclear transfer, at the Laboratory of Molecular Biology in Cambridge, UK (1974). After a series of academic View Full Bio
Dr. Edward Futcher
Non-Executive Director
Dr. Futcher holds a B.Sc. in Physics and a Ph.D. in Physics from the University of London and has extensive experience in engineering and management in high technology companies. Since 1997, Dr. Futcher has held non-executive View Full Bio
Guy Innes ACA
Non-Executive Director
Guy Archibald Innes is a Chartered Accountant and a member of the Institute of Chartered Accountants in England and Wales.
Mr. Innes has extensive experience in financing and managing technology companies, which he gained from serving as View Full Bio
Kim Nguyen
Non-Executive Director
Ms. Nguyen is an international HR professional with over 20 years-experience working with fast growing multinational technology companies covering Europe, Middle East & Africa, Latin America and Asia Pacific (“APAC”) markets. Ms. View Full Bio
Richard Brudnick
Non-Executive Director
Mr. Brudnick has held senior positions in the areas of Portfolio Strategy & Business Development and Corporate Development in a number of pharmaceutical companies and currently serves as Chief Business Officer and Head of Corporate View Full Bio
IR Contact Information
Investor Relations
VolitionRx
Scott Powell
T: (646) 650-1351
investorrelations@volition.com
Edison Advisors
Joseph Green
T: (646) 653-7030
jgreen@edisongroup.com
Edison Advisors
Rachel Carroll
T: +44 (0) 20 3077 5711
rcarroll@edisongroup.com
Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.vstocktransfer.com